Identification of novel biomarkers and therapeutic targets for steatohepatitis and advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD): an in silico analysis

被引：0
|
作者：
Maya-Miles, Douglas [1 ,2 ]
Gallego-Duran, Rocio [1 ,2 ]
Munoz Hernandez, Rocio [1 ,2 ]
Rojas, Angela [1 ,2 ]
Gil-Gomez, Antonio [1 ,2 ]
Montero-Vallejo, Rocio [1 ,2 ]
Gato, Sheila [1 ,2 ]
Giraldez-Jimenez, Maria [1 ,2 ]
Ampuero, Javier [1 ,2 ]
Romero Gomez, Manuel [1 ,2 ]
机构：
[1] Univ Seville, Hosp Univ Virgen Rocio, Seliver Grp, Inst Biomed Sevilla IBiS,CSIC, Seville, Spain
[2] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain
来源：
JOURNAL OF HEPATOLOGY | 2020年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT014
引用
收藏
页码：S660 / S660
页数：1
相关论文
共 50 条
  • [31] Immunology of gut microbiome and liver in non-alcoholic fatty liver disease (NAFLD): mechanisms, bacteria, and novel therapeutic targets
    Gruzdev, Stanislav Konstantinovich
    Podoprigora, Irina Viktorovna
    Gizinger, Oksana Anatolievna
    ARCHIVES OF MICROBIOLOGY, 2024, 206 (02)
  • [32] Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in patients with HIV
    Verna, Elizabeth C.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (03): : 211 - 223
  • [33] Validation of serological biomarkers for detection of non-alcoholic fatty liver disease (NAFLD) and/or advanced liver fibrosis in people living with HIV
    Yanavich, C.
    Pacheco, A.
    Cardoso, S.
    Nunes, E.
    Chaves, U.
    Santos, R.
    Morata, M.
    Veloso, V. G.
    Grinsztejn, B.
    Perazzo, H.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2019, 22 : 5 - 6
  • [34] Type 2 diabetics with non-alcoholic fatty liver disease: a significant predictor of non-alcoholic steatohepatitis and advanced fibrosis
    Ching, Helena L.
    Tan, Jeremy H.
    Jeffrey, Gary P.
    Macquillan, Gerry
    Adams, Leon A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 : A35 - A36
  • [35] PERFORMANCE OF ENHANCED LIVER FIBROSIS (ELF) TEST TO PREDICT ADVANCED FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
    Younossi, Zobair M.
    Felix, Sean
    Jeffers, Thomas
    Younossi, Elena
    Nader, Fatema
    Pham, Huong
    Afendy, Arian
    Cable, Rebecca
    Racila, Andrei
    Younoszai, Zahra
    Lam, Brian P.
    Golabi, Pegah
    Henry, Linda
    Stepanova, Maria
    HEPATOLOGY, 2020, 72 : 934A - 935A
  • [36] SERUM DES-ACYLGHRELIN CONCENTRATION IS ASSOCIATED WITH HISTOLOGIC NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
    Estep, M.
    Vernon, G.
    Wang, L.
    Stepanova, M.
    Younoszai, A.
    Elariny, H.
    Goodman, Z.
    Chandhoke, V.
    Baranova, A.
    Younossi, Z.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S350 - S351
  • [37] HLA Class II Alleles Are Strongly Associated with Non-alcoholic Fatty Liver Disease (NAFLD), Non-alcoholic Steatohepatitis (NASH) and Fibrosis
    Karrar, Azza
    Li, Zheng
    Moosvi, Ali M.
    Hariharan, Siddharth
    Fang, Yun
    Stepanova, Maria
    Goodman, Zachary D.
    Younossi, Zobair
    HEPATOLOGY, 2014, 60 : 601A - 602A
  • [38] CHARACTERIZING AND PREDICTING NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND ADVANCED FIBROSIS IN NON-OBESE NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN ASIA - THE GOASIA INITIATIVE.
    Lee, Wei Jie Jonathan
    Tan, Xiang Xuan Eunice
    Chan, Wah Keong
    Treeprasertsuk, Sombat
    Goh, George Boon Bee
    Fan, Jian-Gao
    Song, Myeong Jun
    Charatcharoenwitthaya, Phunchai
    Duseja, Ajay K.
    Imajo, Kento
    Nakajima, Atsushi
    Seki, Yosuke
    Kasama, Kazunori
    Kakizaki, Satoru
    Lesmana, Laurentius A.
    Ho, Khek Yu
    Goh, Khean Lee
    Wong, Vincent Wai-Sun
    Dan, Yock Young
    HEPATOLOGY, 2019, 70 : 25A - 26A
  • [39] Validation of the "NAFLD fibrosis score" in predicting advanced fibrosis in patients with histologically proven non-alcoholic fatty liver disease
    Kang, Hellan
    Omo, Jason
    Joel, Greenson
    Lok, Anna S.
    Conjeevaram, Hari S.
    HEPATOLOGY, 2007, 46 (04) : 750A - 750A
  • [40] The role and mechanism of pyroptosis and potential therapeutic targets in non-alcoholic fatty liver disease (NAFLD)
    Li, Shu-Jing
    Liu, An-Bu
    Yu, Yuan-Yuan
    Ma, Jin-Hai
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12
12345